ArticleContemporary oncology (Poznan, Poland)2019

The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment.

Belkıs Nihan Coskun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.